Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × SCIO-469 × Clear all

NCT00087867 2010-10-18

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell